NASDAQ · CHRN

ChronoScale Holdings Corporation

$18.39 -$3.11 (-14.47%) 1D Market open

Key Metrics

$3.12B
Market cap
P/E · TTM
Revenue · TTM
−$3.99M
Net income
EPS · TTM $-2.36
Dividend yield
Free cash flow
Beta · 1Y
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jul 15
    The stock moved +28.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jul 15
  • Jul 2
    From its Jun 23 high, the share price fell 36%.

    Peak close $25.82 on Jun 23; trough close $16.49 on Jul 2. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -36%
  • May 28
    The stock moved +23.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 28

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$3.12B
Enterprise value
Shares outstanding145.2M
52-wk range$12.27 – $30.00
Avg volume · 20D402.5K
Net cash
Book value / share$1.23
IndustryGeneral Industrial Machinery & Equipment, Nec
ExchangeNASDAQ
About ChronoScale Holdings Corporation
IPO dateMay 5, 2026
Employees

ChronoScale Holdings Corp is being formed to become an accelerated compute platform purpose-built to support the demanding artificial intelligence workloads.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC -54.0% · —

Financial Health

Current ratio1.55
Quick ratio1.03
Debt / equity
Debt / EBITDA
Net cash
Working capital$4.96M

Cash Flow · TTM

Operating CF
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

0 / 9
Weak fundamentals · 0 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings